Summary & Overview
CPT 3472F: Rheumatoid Arthritis High Disease Activity Score
CPT code 3472F denotes a high rheumatoid arthritis (RA) disease activity score and is used to document patients with elevated disease activity who may require medication adjustment or intensified management. Nationally, tracking RA disease activity is central to quality measurement, clinical decision-making, and value-based care programs focused on improving outcomes for people with autoimmune inflammatory disease. This code signals clinically significant inflammation and pain that can affect therapeutic choices.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find concise coverage context, payer inclusion, and the clinical purpose of the code. The publication provides benchmarks and policy-relevant context for how the code is used in outpatient rheumatology and ambulatory specialty settings, and summarizes clinical implications for treatment adjustment when high disease activity is documented.
This summary frames what the billing code represents, why it matters for national quality measurement and care pathways, and what to expect in the full publication: payer coverage patterns, benchmark metrics where available, and the clinical context for use of the score in treatment planning. Data not available in the input will be noted in detail sections.
Billing Code Overview
CPT code 3472F reports a high rheumatoid arthritis (RA) disease activity score. The measure indicates that the patient's RA disease activity level is elevated, reflecting higher degrees of inflammation and patient-reported pain. Results from this score can inform adjustments to RA medication and management.
Service type: Disease activity assessment for rheumatoid arthritis
Typical site of service: Outpatient specialty clinic (rheumatology) or ambulatory care setting
Clinical & Coding Specifications
Clinical Context
A 56-year-old female with established seropositive rheumatoid arthritis presents for routine rheumatology follow-up. She reports worsening morning stiffness, increased joint pain in the wrists and hands, and fatigue despite stable disease-modifying antirheumatic drug therapy. The clinician performs a rheumatoid arthritis disease activity assessment to quantify inflammation and functional impact, using a validated composite instrument that integrates tender/swollen joint counts, patient global assessment, and an inflammatory marker. Results indicate high disease activity, prompting the provider to document the score, review current therapy, discuss treatment options, and plan a medication adjustment or escalation.
Typical workflow: patient check-in → focused history of symptoms and medication adherence → physical exam with tender and swollen joint counts → order or review laboratory inflammatory marker (if needed) → calculation and documentation of the rheumatoid arthritis disease activity score → clinical decision-making documented in the encounter note and medication plan recorded for follow-up.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of a procedure | Use when a distinct E/M visit occurs with documentation beyond the disease activity scoring encounter |